ZA971987B - Quinoxalinediones - Google Patents

Quinoxalinediones

Info

Publication number
ZA971987B
ZA971987B ZA971987A ZA971987A ZA971987B ZA 971987 B ZA971987 B ZA 971987B ZA 971987 A ZA971987 A ZA 971987A ZA 971987 A ZA971987 A ZA 971987A ZA 971987 B ZA971987 B ZA 971987B
Authority
ZA
South Africa
Prior art keywords
quinoxalinediones
Prior art date
Application number
ZA971987A
Other languages
English (en)
Inventor
David John Bull
Christopher Lee Carr
Michael Jonathan Fray
Elisabeth Colette Loui Gautier
Charles Eric Mowbray
Alan Stobie
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of ZA971987B publication Critical patent/ZA971987B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
ZA971987A 1996-03-09 1997-03-07 Quinoxalinediones ZA971987B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9605027.3A GB9605027D0 (en) 1996-03-09 1996-03-09 Quinoxalinediones

Publications (1)

Publication Number Publication Date
ZA971987B true ZA971987B (en) 1998-09-07

Family

ID=10790134

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA971987A ZA971987B (en) 1996-03-09 1997-03-07 Quinoxalinediones

Country Status (42)

Country Link
US (1) US6376490B1 (no)
EP (1) EP0885212B1 (no)
JP (1) JP3110467B2 (no)
KR (1) KR100288099B1 (no)
CN (1) CN1103770C (no)
AP (1) AP767A (no)
AR (1) AR006119A1 (no)
AT (1) ATE208773T1 (no)
AU (1) AU717972B2 (no)
BG (1) BG63340B1 (no)
BR (1) BR9707851A (no)
CA (1) CA2248366C (no)
CO (1) CO4770976A1 (no)
CZ (1) CZ292792B6 (no)
DE (1) DE69708269T2 (no)
DK (1) DK0885212T3 (no)
DZ (1) DZ2188A1 (no)
EA (1) EA001730B1 (no)
ES (1) ES2163742T3 (no)
GB (1) GB9605027D0 (no)
HN (1) HN1998000034A (no)
HR (1) HRP970132A2 (no)
HU (1) HUP9900975A3 (no)
ID (1) ID18112A (no)
IL (1) IL125491A (no)
IS (1) IS4811A (no)
MA (1) MA26422A1 (no)
NO (1) NO984058L (no)
NZ (1) NZ331060A (no)
OA (1) OA10850A (no)
PE (2) PE43398A1 (no)
PL (1) PL329032A1 (no)
PT (1) PT885212E (no)
SI (1) SI0885212T1 (no)
SK (1) SK283467B6 (no)
TN (1) TNSN97044A1 (no)
TR (1) TR199801782T2 (no)
TW (1) TW454004B (no)
UY (1) UY24482A1 (no)
WO (1) WO1997032873A1 (no)
YU (2) YU39698A (no)
ZA (1) ZA971987B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199902055T2 (xx) * 1997-02-27 2000-07-21 Pfizer Inc. Kinoksalindiyonlar.
AP982A (en) * 1997-02-27 2001-07-16 Pfizer Quinoxalinediones.
US6340758B1 (en) * 1997-05-16 2002-01-22 Warner-Lambert Company Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents
DE10005150A1 (de) * 2000-02-07 2001-08-09 Merck Patent Gmbh Verfahren zur Herstellung von 5-Arylnicotinaldehyden
BR0110961A (pt) * 2000-05-19 2004-06-29 Merck Patent Gmbh Derivados de triazol
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
WO2005006945A2 (en) * 2003-07-03 2005-01-27 The Salk Institute For Biological Studies Methods for treating neural disorders and compounds useful therefor
MY145368A (en) * 2004-01-13 2012-01-31 Nissan Chemical Ind Ltd Aminoquinoxaline compounds and polyaminoquinoxaline compounds, and use thereof
JP4827173B2 (ja) 2004-02-06 2011-11-30 国立大学法人山口大学 電気二重層キャパシタ用電極及びその製造方法
JP2007223901A (ja) * 2004-03-24 2007-09-06 Takeda Chem Ind Ltd 複素環化合物およびその用途
US20060211739A1 (en) * 2005-02-08 2006-09-21 Arturo Perez-Medrano Use of selective P2X7 receptor antagonists
WO2007112347A1 (en) * 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
JP5379692B2 (ja) 2006-11-09 2013-12-25 プロビオドルグ エージー 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての3−ヒドロキシ−1,5−ジヒドロ−ピロール−2−オン誘導体
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
US8603980B2 (en) 2007-01-16 2013-12-10 The Johns Hopkins University Glutamate receptor antagonists and methods of use
JP5930573B2 (ja) 2007-03-01 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤の新規使用
DK2142514T3 (da) 2007-04-18 2015-03-23 Probiodrug Ag Thioureaderivater som glutaminylcyclase-inhibitorer
WO2008143019A1 (en) 2007-05-17 2008-11-27 Semiconductor Energy Laboratory Co., Ltd. Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative
EA022007B1 (ru) 2009-09-11 2015-10-30 Пробиодруг Аг Гетероциклические производные в качестве ингибиторов глутаминилциклазы
EP2542549B1 (en) 2010-03-03 2016-05-11 Probiodrug AG Inhibitors of glutaminyl cyclase
EA022420B1 (ru) 2010-03-10 2015-12-30 Пробиодруг Аг Гетероциклические ингибиторы глутаминилциклазы (qc, ec 2.3.2.5)
JP5945532B2 (ja) 2010-04-21 2016-07-05 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体
US8530670B2 (en) 2011-03-16 2013-09-10 Probiodrug Ag Inhibitors
EP2953933A1 (en) * 2013-02-07 2015-12-16 Merck Patent GmbH Substituted acetylene derivatives and their use as positive allosteric modulators of mglur4
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa
CN111548320B (zh) * 2019-10-09 2023-03-24 贵州大学 一类1,3,4-噁二唑酰肼类化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2095444C (en) * 1990-11-06 2001-06-19 Shuichi Sakamoto Fused pyrazine derivatives
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
GB9418443D0 (en) 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
DE4439492A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
TR199902055T2 (xx) * 1997-02-27 2000-07-21 Pfizer Inc. Kinoksalindiyonlar.

Also Published As

Publication number Publication date
KR19990087614A (ko) 1999-12-27
AP9700947A0 (en) 1997-04-30
SK283467B6 (sk) 2003-08-05
HN1998000034A (es) 1999-02-09
CZ286498A3 (cs) 1999-07-14
AP767A (en) 1999-09-29
GB9605027D0 (en) 1996-05-08
ID18112A (id) 1998-03-05
DE69708269D1 (de) 2001-12-20
BR9707851A (pt) 1999-07-27
CO4770976A1 (es) 1999-04-30
CN1103770C (zh) 2003-03-26
DZ2188A1 (fr) 2002-12-02
IL125491A (en) 2003-07-06
EP0885212A1 (en) 1998-12-23
EA001730B1 (ru) 2001-08-27
CA2248366C (en) 2002-06-04
AR006119A1 (es) 1999-08-11
CN1213369A (zh) 1999-04-07
HUP9900975A2 (hu) 1999-07-28
NZ331060A (en) 2000-01-28
EA199800702A1 (ru) 1999-04-29
NO984058L (no) 1998-11-06
NO984058D0 (no) 1998-09-03
AU2023197A (en) 1997-09-22
DK0885212T3 (da) 2002-03-25
TR199801782T2 (xx) 1998-12-21
CA2248366A1 (en) 1997-09-12
PT885212E (pt) 2002-02-28
YU39698A (sh) 1999-03-04
HRP970132A2 (en) 1998-06-30
DE69708269T2 (de) 2002-07-25
SK121498A3 (en) 2000-10-09
JPH11506123A (ja) 1999-06-02
PL329032A1 (en) 1999-03-01
MA26422A1 (fr) 2004-12-20
UY24482A1 (es) 2000-09-29
TNSN97044A1 (fr) 2005-03-15
OA10850A (en) 2001-08-16
TW454004B (en) 2001-09-11
ATE208773T1 (de) 2001-11-15
JP3110467B2 (ja) 2000-11-20
EP0885212B1 (en) 2001-11-14
YU41199A (sh) 2001-09-28
WO1997032873A1 (en) 1997-09-12
BG102760A (en) 1999-09-30
PE58199A1 (es) 1999-06-11
CZ292792B6 (cs) 2003-12-17
ES2163742T3 (es) 2002-02-01
PE43398A1 (es) 1998-08-29
AU717972B2 (en) 2000-04-06
HUP9900975A3 (en) 2001-12-28
KR100288099B1 (ko) 2001-05-02
BG63340B1 (bg) 2001-10-31
SI0885212T1 (en) 2002-02-28
US6376490B1 (en) 2002-04-23
IS4811A (is) 1998-07-27
IL125491A0 (en) 1999-03-12

Similar Documents

Publication Publication Date Title
DE69634986D1 (en) Modulares wandlersystem
DE59704951D1 (en) Plättchenförmiges titandioxidpigment
DE69715838D1 (en) Thermomorphe drucksensitive klebmittel
DE69608577D1 (en) Thermostabiler schalldämmstoff
DE69711882D1 (en) Carbolinderivate
DE69702926D1 (en) Polyurethanhartschäume
DE69705420D1 (en) Polyurethanhartschäume
DE69708059D1 (en) Thiophenopyrimidine
IL125491A0 (en) Quinoxalinediones
DE59705192D1 (en) Lcp-blends
DE59711450D1 (en) Arylalkanoylpyridazine
DE59700372D1 (en) Blockcopolymere
DE69703480D1 (en) Anionische photokatalysator
DE69621466D1 (en) Thermoplastische hydroxy-phenoxyetherpolymerverbundwerkstoffe
GB9711989D0 (en) Handleset
DE69710573D1 (en) Morpholinyl-anthracyclinderivate
DE59707730D1 (en) Peripheralpumpe
DE59704086D1 (en) Twin-dualmode-filter
DE59703905D1 (en) Linearmotorgetriebene transportanlage
DE59711583D1 (en) Heterocyclyluracile
DE59702027D1 (en) Bragg-modulator
DE59703023D1 (en) Cyclopeptidderivate
DE69719071D1 (en) Phenanthridiniumderivate
DE59709914D1 (en) Substituierte aromatische phosphonsäurederivate
IL131120A0 (en) Quinoxalinediones